These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 20484479

  • 1. Treatment of type B insulin resistance: a novel approach to reduce insulin receptor autoantibodies.
    Malek R, Chong AY, Lupsa BC, Lungu AO, Cochran EK, Soos MA, Semple RK, Balow JE, Gorden P.
    J Clin Endocrinol Metab; 2010 Aug; 95(8):3641-7. PubMed ID: 20484479
    [Abstract] [Full Text] [Related]

  • 2. Combined Immunosuppressive Therapy Induces Remission in Patients With Severe Type B Insulin Resistance: A Prospective Cohort Study.
    Klubo-Gwiezdzinska J, Lange M, Cochran E, Semple RK, Gewert C, Brown RJ, Gorden P.
    Diabetes Care; 2018 Nov; 41(11):2353-2360. PubMed ID: 30201849
    [Abstract] [Full Text] [Related]

  • 3. Successful treatment of type B insulin resistance with rituximab.
    Manikas ED, Isaac I, Semple RK, Malek R, Führer D, Moeller LC.
    J Clin Endocrinol Metab; 2015 May; 100(5):1719-22. PubMed ID: 25675382
    [Abstract] [Full Text] [Related]

  • 4. Rituximab therapy for the type B syndrome of severe insulin resistance.
    Coll AP, Thomas S, Mufti GJ.
    N Engl J Med; 2004 Jan 15; 350(3):310-1. PubMed ID: 14724317
    [No Abstract] [Full Text] [Related]

  • 5. Type B Insulin Resistance Masquerading as Ovarian Hyperthecosis.
    Brown RJ, Joseph J, Cochran E, Gewert C, Semple R, Gorden P.
    J Clin Endocrinol Metab; 2017 Jun 01; 102(6):1789-1791. PubMed ID: 27911591
    [Abstract] [Full Text] [Related]

  • 6. Clinical efficacy of insulin-like growth factor-1 in a patient with autoantibodies to insulin receptors: a case report.
    Yamamoto T, Sato T, Mori T, Yamakita T, Hasegawa T, Miyamoto M, Hosoi M, Ishii T, Yoshioka K, Tanaka S, Fujii S.
    Diabetes Res Clin Pract; 2000 Jul 01; 49(1):65-9. PubMed ID: 10808065
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Antibody-Mediated Extreme Insulin Resistance: A Report of Three Cases.
    Kim HN, Fesseha B, Anzaldi L, Tsao A, Galiatsatos P, Sidhaye A.
    Am J Med; 2018 Jan 01; 131(1):102-106. PubMed ID: 28822702
    [Abstract] [Full Text] [Related]

  • 9. Insulin receptor antibodies and insulin resistance.
    Magsino CH, Spencer J.
    South Med J; 1999 Jul 01; 92(7):717-9. PubMed ID: 10414483
    [Abstract] [Full Text] [Related]

  • 10. Clinical course of the syndrome of autoantibodies to the insulin receptor (type B insulin resistance): a 28-year perspective.
    Arioglu E, Andewelt A, Diabo C, Bell M, Taylor SI, Gorden P.
    Medicine (Baltimore); 2002 Mar 01; 81(2):87-100. PubMed ID: 11889410
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Regression of acanthosis nigricans correlates with disappearance of anti-insulin receptor autoantibodies and achievement of euglycemia in type B insulin resistance syndrome.
    Fareau GG, Maldonado M, Oral E, Balasubramanyam A.
    Metabolism; 2007 May 01; 56(5):670-5. PubMed ID: 17445543
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Type B insulin resistance complicated with systemic lupus erythematosus.
    Kawashiri SY, Kawakami A, Fujikawa K, Iwamoto N, Aramaki T, Tamai M, Nakamura H, Origuchi T, Ida H, Eguchi K.
    Intern Med; 2010 May 01; 49(5):487-90. PubMed ID: 20190490
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Case report: Successful combination therapy with double-filtration plasmapheresis and rituximab under the condition of the use of a sensor-augmented pump for type B insulin resistance syndrome.
    Osanami A, Kanda M, Sato T, Akazawa C, Baba S, Komatsu H, Murase K, Yamashita T, Yano T.
    Front Endocrinol (Lausanne); 2022 May 01; 13():997296. PubMed ID: 36157458
    [Abstract] [Full Text] [Related]

  • 18. Successful treatment with plasmapheresis, cyclophosphamide, and cyclosporin A in type B syndrome of insulin resistance. Case report.
    Eriksson JW, Bremell T, Eliasson B, Fowelin J, Fredriksson L, Yu ZW.
    Diabetes Care; 1998 Aug 01; 21(8):1217-20. PubMed ID: 9702422
    [Abstract] [Full Text] [Related]

  • 19. Remission of chronic thrombotic thrombocytopenic purpura after treatment with cyclophosphamide and rituximab.
    Zheng X, Pallera AM, Goodnough LT, Sadler JE, Blinder MA.
    Ann Intern Med; 2003 Jan 21; 138(2):105-8. PubMed ID: 12529092
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.